ADIPOQ and type 2 diabetes mellitus: This meta-analysis suggests that the overall risk of type 2 diabetes mellitus is strongly associated with elevated levels of inflammatory cytokines, specifically tumor necrosis factor-α, and low levels of adiponectin (Figure 2).